Drug Week
Susan Hasty, Publisher
Table of Contents . . . November 1st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Alzheimer Disease - Antipsychotic drug has few side effects
Technology - AI designed for telecommunications will speed drug development
Addiction Medicine - New drug may help recovering cocaine addicts
Diabetic Nephropathy - FDA approves Avapro (irbesartan) to slow kidney disease
HIV/AIDS Therapy - Novel agent effective against cytomegalovirus shedding
Pain Medicine - Positive phase I results reported with intranasal morphine
Rheumatoid Arthritis - Phase II clinical trial of AGIX-4207 initiated
Actinic Keratosis - Solarase marketing agreement announced by SkyePharma and Meditech
Aspergillosis - Itraconazole reduces amphotericin B efficacy against pulmonary aspergillosis
Atherosclerosis - Developer of HDL therapies begins second clinical study of RLT peptide (ETC-642)
Bone Fractures - E.C. approves MAA for recombinant protein treatment for tibia fractures
Cervical Cancer - Phase I/II study of RSR13 initiated
Chlamydia - Preclinical efficacy studies: Antex STD vaccine protects against infection
Choroidal Neovascularization - Results of small photodynamic therapy study reported
Compliance - InnaPhase signs technology agreement
Conscious Sedation - Sicor wins ANDA approval for propofol injection emulsion 10 mL
Diabetic Neuropathy - Patients with type 2 diabetes find walking easier after sulodexide treatment
Diphenhydramine - ACAAI: Sedating antihistamine may double risk of serious injury
Drug Delivery - New report examines drug delivery technologies
Dyslipidemia - New patent granted for Niaspan-based cholesterol products
Epilepsy - Pregabalin may not save epilepsy drug market from generic erosion
Glioma - U.S. issues two patents to protect chlorotoxin
Glucose Control - Enrollment for Symlin dose titration study completed
Helicobacter Pylori - FDA issues nonapprovable letter for Helicide
Hepatitis B Virus - FDA approves Hepsera for treatment of chronic hepatitis B
Juvenile Rheumatoid Arthritis - Clinical trials initiated to explore use of adalimumab
Legal Issues - Manufacturing process of Eprex in question
Lymphoblastic Leukemia - Web site provides patient eligibility information for clinical trials
Opioid Bowel Dysfunction - Enrollment for study of Alvimopan completed
Pain Management - IND filed for buccal fentanyl with Health Canada
Pediatric HIV/AIDS - Vitamin A supplements improve infant nutrition, but not infection risk
Postoperative Pain - Positive results reported from phase I/II study with Intranasal Ketamine
Prostate Cancer - Eligard 22.5 mg launched as palliative treatment for advanced prostate cancer
Regulatory Issues - Switching drugs from prescription to OTC raises concerns
Rheumatoid Arthritis - Initial accrual complete in HuMax-CD4 phase II study
Schizophrenia - Seroquel effective across full spectrum of schizophrenia symptoms
Schizophrenia - U.S. FDA issues approvable letter for aripiprazole
Smallpox - Phase I vaccine trial yields positive results
Smoking Cessation - OTC sales of quitting aids up, effectiveness down
Staphylococcus Aureus - Phase I study of Veronate initiated in premature infants
Stem Cell Transplantation - High-dose antibiotics can prevent etoposide-related infections
Stem Cell Transplantation - Mycophenolate mofetil effective against GvHD but carries high infection risk
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
